Tackling a scandal of premature mortality; time for a ‘hearts & minds’ approach by Shiers, David & Kendall, Tim
5/19/2017 Health and Social Care – Tackling a scandal of premature mortality; time for a ‘hearts & minds’ approach
http://blogs.lse.ac.uk/healthandsocialcare/2012/07/06/tackling­a­scandal­of­premature­mortality­time­for­a­hearts­minds­approach/ 1/5





Compared with the general population, those with severe mental illnesses like schizophrenia die on
average 20.5 years earlier in men, and 16.4 years earlier in women
While a third of these premature deaths are due to suicide, two-thirds are due to the same sorts of
physical illnesses that affect the general population, particularly type 2 diabetes and cardiovascular
diseases
Over 10% of people taking antipsychotic medication develop type 2 diabetes (2-3 times the rate for the
general population) and can then expect 50% poorer survival rates than their non-psychiatric peers with
diabetes alone
Between 37% and 86% of those experiencing a first episode of psychosis gained more than 7% of their







12kg  on  average  within  two  years?  Hardly  surprising  medicines  get  discarded  and  clinic
appointments missed, setting up a cycle of relapsing illness and disillusion with life ahead.
This  scenario  happens…  or  maybe  it’s  to  a  close  friend  or  family  member.  Psychosis
(schizophrenia  or  bipolar  disorder)  often  starts  in  late  teens/twenties  at  a  critical  development
stage with a  lifetime ahead. Many may  face a  future not only  limited by stigmatising psychiatric
illness  but  also  a  life  restricted  and  shortened  by  physical  ill­health,  particularly  cardiovascular
disease  (CVD)  and  diabetes?  Such  problems  can  be  compounded  by  disorganised  health
services and disputed responsibilities for their physical healthcare between GPs and psychiatrists,
































Choices  ‘Half of UK obese by 2030’). Sedentary  lifestyles and easy access  to energy­rich  foods
underpin an alarming increase in obesity and obesity­related illness particularly in young people.
Those with psychosis are not immune to these influences. Indeed social exclusion, sedentary lives
and  poverty  may  exacerbate  the  problem.  However  what  particularly  sets  apart  people  with
emerging  psychosis  is  exposure  to  antipsychotic  medication,  especially  when  young  and
physically maturing.  Even  prior  to  antipsychotic  initiation  unrelieved  stress/distress  can  provoke
neuro­endocrine  changes  affecting  glucose  metabolism  and  fat  distribution.  But  within  weeks,
antipsychotic  medicines  can  dramatically  accelerate  weight  gain  alongside  other  adverse
metabolic changes (Editorial Lancet 2011). Lack of good quality research has led to over­reliance
on  short  duration  trials  involving  people  with  established  illness,  many  of  whom  had  already
gained weight  from  previous  antipsychotic  exposure.  This may  have  led  to  a  three  to  four  fold
underestimate  of  weight  gain  in  people  exposed  to  antipsychotics  for  the  first  time  [Alvarez­
Jimanez et al. 2008]. Marketing may have underplayed the adverse effects that all antipsychotics





A  lack of high quality  research and pharmaceutical marketing may have  led  to a  three  to  four










biochemically  a  population  with  schizophrenia,  average  age  38,  for  previously  undiagnosed
diabetes. 10% were discovered  to have diabetes   and 38% pre­diabetes  (approximately 25% of
these can expect to become diabetic within 3­5 years), showing how people journey from normal





Thus weight gain, metabolic change and smoking mean  that by  the  time people with psychosis
reach their 30­40s, many are established on a path towards future CVD, diabetes and premature
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Who is at risk: people with emerging psychosis, usually in late teens / twenties 
When to target prevention: early phase of illness around antipsychotic initiation
Which are the key lifestyle issues: smoking; poor diet; lack of exercise
Which specific modifiable risks: primary care’s Quality and Outcomes Framework already encourages
mental health monitoring of: BMI (MH12); blood pressure (MH13); total to HDL cholesterol ratio (MH14);
blood glucose (MH15)
How to prevent or delay the onset of diabetes and CVD: combination of increased activity, improved diet
and weight loss; high quality antipsychotic prescribing; use of metformin (drug previously reserved for
diabetes) in those at particularly high risk for developing diabetes
Early access to really good quality services providing evidence-based interventions for people with a first
episode of psychosis is a clinical priority for mental health services (NHS Confederation review):  the
specialist service ethos is receptive to the prevention paradox. 
Thus  the  prevention  paradox  is  feasible.  The  next  critical  step  is  to  innovate  new  service
approaches. 
Encouragingly,  an  early  intervention  body  &  mind  service  model  has  recently  been  introduced
across New South Wales – providing an approach based on an agreed clinical algorithm*** which
promotes positive physical  lifestyle whilst attending  to key cardiovascular  risks – notably weight
gain,  smoking,  lipid  and  glucose  abnormalities  and  hypertension  (Curtis  et  al.  2012).  This
programme has stimulated much interest in the UK.
A new pilot has recently commenced between Sheffield Health and Social Care NHS Foundation





















***  Download  Positive  Cardiometabolic  Health  Algorithm  from    New  South  Wales  Training
Programme website
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